Patriot Financial Group Insurance Agency’s BioMarin Pharmaceuticals BMRN Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-400	Closed	-$33K	–	587
2022 Q2	$33K	Hold	400	–	–	0.01%	860
2022 Q1	$31K	Hold	400	–	–	0.01%	924
2021 Q4	$35K	Hold	400	–	–	0.01%	997
2021 Q3	$31K	Sell	400 -1,100	-73%	-$86.8K	0.01%	1027
2021 Q2	$125K	Hold	1,500	–	–	0.02%	558
2021 Q1	$113K	Hold	1,500	–	–	0.03%	520
2020 Q4	$132K	Buy	1,500 +1,097	+272%	+$87K	0.03%	425
2020 Q3	$31K	Sell	403 -299	-43%	-$30.3K	0.01%	659
2020 Q2	$87K	Buy	702 +102	+17%	+$10.1K	0.03%	380
2020 Q1	$51K	Sell	600 -8	-1%	-$689	0.02%	447
2019 Q4	$51K	Sell	608 -1	-0.2%	-$76	0.02%	471
2019 Q3	$41K	Sell	609 -200	-25%	-$15.4K	0.02%	475
2019 Q2	$68K	Hold	809	–	–	0.03%	387
2019 Q1	$72K	Buy	809 +209	+35%	+$19.4K	0.04%	325
2018 Q4	$51K	Buy	+600	New	+$57.1K	0.03%	320

Other funds holding BMRN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Patriot Financial Group Insurance Agency's BMRN Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2022, closing a stake of 400 shares — an estimated $33K sold.

Patriot Financial Group Insurance Agency first reported a position in BMRN in Q4 2018 and held it in 15 quarters. The position peaked at $132K in Q4 2020. 552 funds tracked by Wall St. Rank hold BMRN as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining BioMarin Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 400 BioMarin Pharmaceuticals shares in Q3 2022, an estimated $33K.
Patriot Financial Group Insurance Agency first reported a position in BioMarin Pharmaceuticals in Q4 2018 and held it in 15 quarters.
Patriot Financial Group Insurance Agency's BioMarin Pharmaceuticals position peaked at $132K in Q4 2020.
552 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.